We are live on ! Find out more
HURA

TuHURA Biosciences
HURA

24 hedge funds and large institutions have $1.99M invested in TuHURA Biosciences in 2021 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 6 increasing their positions, 1 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

500% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 1

20% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 5

0% more funds holding

Funds holding: 24 → 24 (0)

0% less ownership

Funds ownership: 0.01% → 0% (-0%)

57% less capital invested

Capital invested by funds: $4.65M → $1.99M (-$2.65M)

Holders
24
Holders Change
–
Holders Change %
0%
% of All Funds
0.37%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
6
Reduced
1
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$226K
2
Citadel Advisors
Citadel Advisors
Florida
+$192K
3
Geode Capital Management
Geode Capital Management
Massachusetts
+$174K
4
Renaissance Technologies
Renaissance Technologies
New York
+$157K
5
VF
Virtu Financial
New York
+$39.2K

Top Sellers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
-$1.75M
2
BFM
Boothbay Fund Management
New York
-$403K
3
GSEP
Golden State Equity Partners
California
-$55K
4
RE
RBC Europe
United Kingdom
-$32.4K
5
RFA
Reilly Financial Advisors
California
-$22K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$723K +$226K +167 +26%
NCM
2
Nantahala Capital Management
Connecticut
$338K – – –
Geode Capital Management
3
Geode Capital Management
Massachusetts
$264K +$174K +129 +77%
S
4
swisspartners
Liechtenstein
$142K – – –
Citadel Advisors
5
Citadel Advisors
Florida
$127K +$192K +142 New
Renaissance Technologies
6
Renaissance Technologies
New York
$104K +$157K +116 New
State Street
7
State Street
Massachusetts
$59K – – –
BlackRock
8
BlackRock
New York
$49K +$17.6K +13 +31%
VF
9
Virtu Financial
New York
$33K +$39.2K +29 +363%
TSS
10
Two Sigma Securities
New York
$24K +$36.5K +27 New
Northern Trust
11
Northern Trust
Illinois
$23K – – –
Two Sigma Investments
12
Two Sigma Investments
New York
$18K -$14.9K -11 -35%
Susquehanna International Group
13
Susquehanna International Group
Pennsylvania
$16K +$24.3K +18 New
Two Sigma Advisers
14
Two Sigma Advisers
New York
$15K +$23K +17 New
ECM
15
Evergreen Capital Management
Washington
$13K – – –
Osaic Holdings
16
Osaic Holdings
Arizona
$13K +$20.3K +15 New
RJA
17
Raymond James & Associates
Florida
$8K – – –
FNB
18
Farmers National Bank
Kentucky
$5.74K – – –
EVM
19
Eaton Vance Management
Massachusetts
$5K – – –
MWM
20
Maltin Wealth Management
New Jersey
$5K – – –
Morgan Stanley
21
Morgan Stanley
New York
$4K +$2.7K +2 +67%
Koshinski Asset Management
22
Koshinski Asset Management
Illinois
$2.04K +$1.35K +1 +100%
UBS Group
23
UBS Group
Switzerland
$2K – – –
LC
24
Lindbrook Capital
California
$1K – – –
AC
25
Armistice Capital
New York
– -$1.75M -1,163 Closed
1
2

HURA Hedge Fund Activity: Q4 2021 in Review

24 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in TuHURA Biosciences (HURA) for Q4 2021, worth a combined $1.99M — down 57% from $4.65M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new HURA positions and 5 closed out — a net gain of 1 holder — while 6 added to existing stakes and 1 trimmed.

The largest buyer was Vanguard Group, adding an estimated $226K. The largest seller was Armistice Capital, exiting entirely with an estimated $1.75M sold.

  • 24 institutional investors held TuHURA Biosciences (HURA) as of Q4 2021, unchanged from Q3 2021.
  • Funds reported $1.99M of TuHURA Biosciences stock for Q4 2021, down 57% quarter-over-quarter.
  • 6 funds opened new TuHURA Biosciences positions in Q4 2021 and 5 closed out, a net change of +1 holder.
  • The largest TuHURA Biosciences buyer in Q4 2021 was Vanguard Group, an estimated $226K added.
  • The largest TuHURA Biosciences seller in Q4 2021 was Armistice Capital, an estimated $1.75M sold.

Based on aggregated 13F filings for Q4 2021.